Desi sickle cell anaemia drug to cost less than 1% of imported versions

Credit: IndiaTimes- Published on March 17, 2024
Hydroxyurea, a drug used to treat sickle cell anaemia, will now be accessible in India for Rs 600 per vial, a fraction of the cost of imported versions. Unlike the global brands priced at around Rs 77,000 per vial, needing specific storage at 2-8 degrees Celsius, the Indian variant by Delhi-based Akums Drugs and Pharmaceuticals...

You are here


💡 newsR Knowledge: Other News Mentions

Delhi

City and Union territory of India
Sisodia approached the high court after a trial court refused to grant him bail in the matter on April 30.
Credit: DNA - Published 10 hours ago

Election Commission transfers Sujata R Kartikeyan due to alleged public office misuse and BJP's accusations of voter influence for BJD. BJP delegation demands..
Credit: IndiaTimes - Published 13 hours ago

Delhi high court has permanently restrained use of the ‘Vigoura’ mark by a homeopathic drug maker to sell its medicine for sexual disorders. The decision was..
Credit: IndiaTimes - Published 13 hours ago

What connects three professors — from Delhi, Kolhapur and Nagpur — to 17 residents of a village in Madhya Pradesh? All of them were in jail as undertrials or..
Credit: IndiaTimes - Published 1 day ago

The extensive operation by Delhi Police, with multiple agencies, aims to trace the sender of a hoax email to schools in Delhi-NCR. The investigation involves..
Credit: IndiaTimes - Published 1 day ago

You might like